A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)

PHASE3CompletedINTERVENTIONAL
Enrollment

3,258

Participants

Timeline

Start Date

September 29, 2021

Primary Completion Date

April 3, 2023

Study Completion Date

April 3, 2023

Conditions
Chikungunya Virus
Interventions
BIOLOGICAL

CHIKV VLP/adjuvant

CHIKV VLP vaccine is comprised of chikungunya virus virus-like particles (CHIKV VLP), adsorbed on aluminum hydroxide adjuvant 2%

BIOLOGICAL

Placebo

Placebo is comprised of formulation buffer

Trial Locations (47)

14609

Rochester Clinical Research, Inc., Rochester

20850

Optimal Research, LLC, Rockville

23502

Alliance for Multispecialty Research, LLC, Norfolk

27612

M3 Wake Research, Inc, Raleigh

28403

Trial Management Associates, LLC, Wilmington

29405

Coastal Carolina Research Center, North Charleston

29621

Synexus Clinical Research US, Inc., Anderson

30322

Emory University School of Medicine, Atlanta

32216

Jacksonville Center for Clinical Research, Jacksonville

32746

Accel Research Sites-DeLand Clinical Research Unit, Lake Mary

32934

Optimal Research, LLC, Melbourne

33173

Suncoast Research Associates, LLC, Miami

33409

Palm Beach Research Center, West Palm Beach

33781

Synexus Clinical Research US, Inc., Pinellas Park

35802

Optimal Research, LLC, Huntsville

36608

Alliance for Multispecialty Research - Mobile, Mobile

37920

Alliance for Multispecialty Research, LLC, Knoxville

40509

Alliance for Multispecialty Research, LLC, Lexington

43213

Aventiv Research Inc., Columbus

44122

Velocity Clinical Rsearch, Inc., Cleveland

45229

Cincinnati Children's Hospital Medical Center - The Gamble Vaccine Research Center, Cincinnati

60602

Synexus Clinical Research US, Inc., Chicago

61614

Optimal Research LLC, Peoria

63104

Saint Louis University, St Louis

63141

Synexus Clinical Research US, Inc., St Louis

64114

Alliance for Multispecialty Research - Kansas City, Kansas City

66219

Johnson County ClinTrials, Lenexa

67114

Alliance for Multispecialty Research, LLC, Newton

67207

Alliance for Multispecialty Research - Wichita East, Wichita

70119

Alliance for Multispecialty Research, LLC, New Orleans

73072

Lynn Institute of Norman, Norman

73112

Lynn Health Science Institute, Oklahoma City

75093

Research Your Health, Plano

77081

Texas Center for Drug Development, Inc., Houston

77375

DM Clinical Research, Tomball

78249

BFHC Research, San Antonio

78613

Velocity Clinical Research, Austin, Cedar Park

80918

Lynn Institute of the Rockies, Colorado Springs

83642

Velocity Clinical Research, Boise, Meridian

84088

Advanced Clinical Research, West Jordan

85281

Alliance for Multispecialty Research, LLC, Tempe

89106

Wr-Crcn, Llc, Las Vegas

89119

Alliance for Multispecialty Research, LLC., Las Vegas

92108

Optimal Research, LLC, San Diego

92220

Velocity Clinical Research, Banning, Banning

97504

Velocity Clinical Research, Medford, Medford

02818

Velocity Clinical Research-Providence, East Greenwich

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
lead

Bavarian Nordic

INDUSTRY

collaborator

Emergent BioSolutions

INDUSTRY